Citigroup’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,900
Closed -$7.52M 5733
2024
Q1
$7.52M Buy
+43,900
New +$8.19M ﹤0.01% 1444
2021
Q1
Sell
-4,200
Closed -$1.07M 7136
2020
Q4
$1.07M Sell
4,200
-5,600
-57% -$1.39M ﹤0.01% 3474
2020
Q3
$2.32M Buy
9,800
+900
+10% +$190K ﹤0.01% 2519
2020
Q2
$1.73M Sell
8,900
-6,900
-44% -$1.32M ﹤0.01% 2986
2020
Q1
$2.62M Sell
15,800
-4,000
-20% -$731K ﹤0.01% 2231
2019
Q4
$3.39M Sell
19,800
-13,300
-40% -$2.22M ﹤0.01% 2396
2019
Q3
$5.46M Buy
33,100
+23,200
+234% +$3.26M ﹤0.01% 1866
2019
Q2
$1.18M Sell
9,900
-5,500
-36% -$564K ﹤0.01% 3425
2019
Q1
$1.46M Buy
15,400
+9,500
+161% +$814K ﹤0.01% 2994
2018
Q4
$468K Buy
5,900
+5,200
+743% +$440K ﹤0.01% 4190
2018
Q3
$74K Buy
+700
New +$65.5K ﹤0.01% 6188

Other funds holding PODD

Citigroup's PODD Position: Q2 2026 in Review

Citigroup increased its Insulet (PODD) stake by 139% in Q2 2026, buying an estimated $15.4M and bringing the position to 158,903 shares worth $24.2M. The position accounts for 0.01% of the portfolio, ranked #1064.

Citigroup first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.7M in Q3 2025. 728 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Citigroup held 158,903 shares of Insulet worth $24.2M as of Q2 2026.
  • Citigroup bought 92,410 Insulet shares in Q2 2026, an estimated $15.4M.
  • Insulet made up 0.01% of Citigroup's portfolio in Q2 2026, its #1064 holding.
  • Citigroup first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Insulet position peaked at $27.7M in Q3 2025.
  • 728 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.